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Abstract
The ability to measure gene expression on a genome-wide scale is one of the most promis-
ing accomplishments in molecular biology. Microarrays, the technology that first permitted
this, were riddled with problems due to unwanted sources of variability. Many of these prob-
lems are now mitigated, after a decade’s worth of statistical methodology development. The
recently developed RNA sequencing (RNA-seq) technology has generated much excitement
in part due to claims of reduced variability in comparison to microarrays. However, we show
RNA-seq data demonstrates unwanted and obscuring variability similar to what was first ob-
served in microarrays. In particular, we find GC-content has a strong sample specific effect on
gene expression measurements that, if left uncorrected, leads to false positives in downstream
results. We also report on commonly observed data distortions that demonstrate the need for
data normalization. Here we describe statistical methodology that improves precision by 42%
without loss of accuracy. Our resulting conditional quantile normalization (CQN) algorithm
combines robust generalized regression to remove systematic bias introduced by deterministic
features such as GC-content, and quantile normalization to correct for global distortions.
1 Introduction
High-throughput sequencing technology is currently being used to quantify gene expression levels
on a genome-wide scale. This is done by first converting RNA transcripts into cDNA fragments,
and then sequencing these fragments to produces millions of sequences of length 35-150 bases
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(bps), referred to as reads. Gene expression is quantified by counting the number of these reads
that map back to each gene. The conventional wisdom is that this approach is an improvement
over microarrays as it is a direct measurement of RNA levels and does not rely on hybridization, a
process known for its lack of specificity (Wu and others, 2004; Zhang and others, 2003; Naef and
Magnasco, 2003). Early studies, based on a small number of samples in highly controlled con-
ditions, found that RNA-seq has excellent technical reproducibility (Mortazavi and others, 2008;
Marioni and others, 2008; Bullard and others, 2010). Furthermore, in a review article Wang and
others (2009) claimed that analysis of RNA-seq data does not require “sophisticated normaliza-
tion”. However, as more data became available, problems such as sequence-specific biases were
reported (Hansen and others, 2010; Li and others, 2010; Pickrell and others, 2010). Here, we
make use of three large, publicly available, RNA-seq data sets to demonstrate that sample specific
systematic biases, along with distortions that affect the overall distribution of count data, introduce
unwanted variation in RNA-seq data that obscures the underlying biological signal.
RNA-seq technology permits applications not previously possible with microarrays. For exam-
ple, it is possible to discover new alternative transcription, unannotated transcription or measure
transcription for non-coding regions (Sultan and others, 2008; Trapnell and others, 2010; Wilhelm
and others, 2010; Perkins and others, 2009). Although most RNA-seq publications have focused
on discovering new transcripts, determining whether the expression level of a genomic unit (such
as a gene, exon, or junction) differs across experimental conditions continues to be an important
question in functional genomics. Therefore, to demonstrate the importance of normalization in
RNA-seq data we focus on the application of differential expression detection (Bottomly and oth-
ers, 2011; Wu and others, 2010; Lefebvre and others, 2011; Anders and Huber, 2010; Robinson
and others, 2010; Eveland and others, 2010).
We start by counting the number of reads in predetermined genomic regions for each sample to
form gene expression matrices with rows representing genes and columns representing samples as
with microarray data. Although our approach is agnostic to the choice of regions, here we used
regions selected to correspond to the canonical definitions of genes as defined by the Ensembl
database (Flicek and others, 2011). Because most tests developed for differential expression test-
ing in microarray data depend on assumptions not necessarily applicable to the count data produced
by RNA-seq, alternative statistical methodologies have been proposed (Anders and Huber, 2010;
Robinson and others, 2010; Robinson and Smyth, 2007, 2008). Similarly, alternative normaliza-
tion approaches have been proposed. The first normalization approach described in the literature
was to simply correct each sample for the number of mapped reads produced for each sample, re-
ferred to as sequencing depth, and each gene for its length (Mortazavi and others, 2008). Because
variability in sequencing depth was observed in technical replicates, it was assumed to be a tech-
nical artifact and because longer genes are expected to have higher counts, Mortazavi and others
(2008) defined the widely used “reads per kilobase per million” (RPKM) measure as the number
of reads mapped to a gene in a sample divided by the product of the length of the gene in kilobases
and the total number of reads mapped in the sample, in millions. Various authors then showed
that sequencing depth is not a stable scaling factor and a number of more robust alternatives were
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suggested (Bullard and others, 2010; Robinson and Oshlack, 2010; Anders and Huber, 2010), with
Langmead and others (2010) suggesting that there might be a gene-specific linear effect of the
sample-specific scaling factor. However, in Section 3 we demonstrate that, even with improved
scaling, the use of the RPKM measure is not a general solution to the unwanted variability prob-
lem. In Section 2 we describe the datasets used throughout the paper and Section 3 motivates the
problem and our solution. In Section 4 we present a useful statistical model and use it to motivate
a normalization algorithm. In Section 5 we present results illustrating the improvements made
possible by our approach. Finally, in Section 6 we discuss future directions and connections to
existing methodology for differential expression detection.
2 Data Description
We examined the three currently available RNA-seq datasets with the largest number of samples
(Pickrell and others, 2010; Montgomery and others, 2010; Cheung and others, 2010). In all three
studies, the samples are lymphoblastoid cell lines from unrelated individuals in the HapMap project
(International HapMap Consortium, 2003). Montgomery and others (2010) sequenced 60 individ-
uals from the CEPH (Utah residents with ancestry from northern and western Europe) population
(CEU). Cheung and others (2010) sequenced 41 individuals also from the CEU population with
29 in common with Montgomery and others (2010). Pickrell and others (2010) sequenced 69 in-
dividuals from Yoruba in Ibadan, Nigeria. All three studies, hereafter referred to as Montgomery,
Pickrell and Cheung, were designed to study the effect of genetics on gene expression and subjects
were considered interchangeable. We therefore used these data to assess improvements in preci-
sion. The samples that were done in replicate across two studies were particularly useful for this
purpose.
To assess accuracy we used samples from Bullard and others (2010), in which two samples from
the microarray quality control study (MAQC Consortium, 2006) were sequenced. These two sam-
ples are Stratagene’s universal human reference RNA (UHR) which is a commercial pool of RNA
from 15 different cell lines, and Ambion’s human brain reference RNA. The same samples have
been assayed extensively on microarrays, and we used data from the MAQC Consortium (2006) in
which each of the two samples was hybridized to five different Affymetrix U133 Plus 2.0 arrays.
The microarrays served as an independent measurement that permitted an assessment of accuracy.
This dataset has no biological replicates, and the technical replicates are based on commercially
available RNA, making the technical noise smaller than what would be expected from tissue sam-
ples.
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2.1 Data Processing
For all datasets the original reads were downloaded, mapped, and the gene expression count ma-
trix created as follows. Reads were aligned to the human reference genome sequence (version
hg19) using Bowtie (Langmead and others, 2009), allowing up to two mismatches. All reads were
trimmed from the 3’ end to be 35bp long, and for the Montgomery data we used the first read of
the paired-end reads. To assign reads to genes we followed essentially the same procedure used by
(Bullard and others, 2010), except for (a) we determined overlap between a read and a genomic
region based on the center base of the trimmed read and not the 5’ end and (b) we used union
gene representations instead of union-intersection gene representation as discussed in Bullard and
others (2010). Sequencing depth was determined as the number of reads mapped to the genome.
3 Motivation
The need for a normalization technique more complex than scaling is first motivated by simply
noting that the distribution of counts across different samples differs (Figure 1(a)). Since the raw
counts are affected by sequencing depth, we also compared the distribution of reads per million
(RPM), in each sample to account for differences in sequencing depth (not shown). The locations
of the peaks of the RPM densities of these replicates became closer, but both the shape and scale
of the distributions still vary between these replicates. Clearly a scaling normalization, that is, a
shift in log scale expression, is not sufficient to normalize counts between samples.
Contrary to an early expectation of RNA-seq technology, the number of reads from a given gene
is not simply determined by the gene expression level. Rather, certain fragments are preferentially
detected in the RNA-seq data acquisition process, leading to nonuniform detection of expression
between genes. We refer to this bias in measurement as counting efficiency. The best documented
example is the effect of the percent of C or G nucleotides in a gene: the so-called GC-content
effect. GC-content has been shown to influence a number of DNA-related measurements. Exam-
ples include gene expression microarrays (Wu and others, 2004; Zhang and others, 2003; Naef
and Magnasco, 2003), copy number arrays (Nannya and others, 2005; Carvalho and others, 2007),
sequencing coverage (Dohm and others, 2008) and RNA-seq (Pickrell and others, 2010). The
difference in counting efficiency between genes means that expression levels cannot be compared
between genes directly. A more subtle and detrimental problem is that these systematic biases
affect different samples differently, thus even within gene comparison between two samples be-
comes problematic. In fact Pickrell and others (2010) demonstrated that the GC-content effect can
change from sample to sample. Here we demonstrate that this appears to be a general problem.
In Figure 1(b) we show the distribution of log2-RPKM for various strata of gene GC-content for
two biological replicates from the Montgomery study. For illustration purposes we selected one
sample in which a higher GC-content leads to increased counting efficiency, and another in which
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there is little impact. This problem has downstream consequences since observed fold changes are
obscured by the variability introduced by GC-content effects (Figure 1(c,d)).
Some work has been done to develop methods to address these effects. Pickrell and others (2010),
the first to notice the sample specific GC-content effect, proposed a sample specific adjustment.
They suggested stratifying predefined genomic regions by GC-content and then for each stratum,
divide the sample counts by the sum of the counts across all samples. This fraction is considered
an enrichment factor for that GC-content stratum, which is then smoothed by GC-content for each
sample separately. Counts are then adjusted by the smoothed enrichment factor. Finally, they pro-
posed doing this on the exon level, adding adjusted counts across all exons from a gene in order to
obtain gene level adjusted counts. We found two problems with this approach that we decided to
improve. First, the enrichment scores are computed for each sample relative to all samples in an
experiment, thus this adjustment does not remove the GC-content effect but rather equalizes the ef-
fect across samples. As a consequence, adjustments vary depending on what samples are processed
together. Second, the GC-content effect is estimated based on the direct summation of counts on
different genes in different samples, ignoring the fact that genes with higher expected counts also
have greater variance. As a result GC-content effects are not entirely removed (Figure 1(e)). In ad-
dition, Roberts and others (2011) addresses bias removal within the Cufflinks transcript assembly
framework (Trapnell and others, 2010) and show improvements in comparisons between sequenc-
ing technologies, but does not address variation between biological replicates.
4 Methods
We present a normalization algorithm motivated by a statistical model that accounts for both the
need to correct systematic biases and the need to adjust for distributional distortions. We denote
the log gene expression level for gene g at sample iwith θg,i, which we consider a random variable.
For most g, θg,i are independent and identically distributed across i. We assume that the marginal
distribution of the θg,i is the same for all samples i, and denote it by G. Note that this variability
accounts for the difference in gene expression across different genes. The p covariates thought to
cause systematic errors are denoted with Xg = (Xg,1, . . . , Xg,p)′. Examples of covariates consid-
ered here are GC-content, gene length, and gene mappability defined as the percentage of uniquely
mapping subreads of a gene. To model the observed counts Yg,i for gene g in sample i we write:









with fi,j(X¯.j) = 0 ∀ j for identifiability. Here, the his are non-decreasing functions that account for
the fact that count distributions are distorted in non-linear ways across the different samples (Fig-
ure 2(a)). The fi,js account for sample dependent systematic biases. Data exploration suggested
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that these are smooth functions, so for tractability we model these as (parametric) natural cubic
splines with known degrees of freedom and knot locations. If there is no technical variability, hi is
the identity function and
∑p
j=1 fi,j(Xg,j) = 0, then the distribution of Ygi for a given i reduces to
a G-Poisson mixture.
With the model in place, obtaining normalized counts is equivalent to estimating θg,i. To do this
we needed to estimate the non-parametric hi functions along with the linear parameters that define
the splines. Note that the distribution of the θg,i in a sample is determined by the biological system,
which varies greatly between species, tissue types and developmental stages. Thus it is unrealistic
to restrict it to a particular parametric family of distributions. This makes estimation requiring full
likelihood, including maximum likelihood estimation (MLE) and Bayesian approaches unsuitable.
In addition, outliers can arise because of either biological activity or technical artifacts. Since both
h and f represent the global impact of systematic effects on all genes in general, it is crucial to
define estimation procedures that are robust to outliers. We take advantage of the large amount
of data for each sample and our parsimonious model to define a stable algorithm which we now
motivate and describe.
For any given i, the distribution of hi(θg,i) is unspecified and Figure 2(b) shows that values can
range from −∞ to 8. First we observe that when µg,i is large, log(Yg,i) |µg,i is approximately
normal with mean log(µg,i) and variance 1/µg,i. The small variance implies that for large µg,i




showing that for a fixed i and large µg,i, the distribution of log(Yg,i) is equal to hi(θg,i) except for
a location shift given by
∑p
j=1 fi,j(Xg,j). Even though the shape of hi(G) is left unspecified, the
quantiles of log(Yg,i) shift by
∑p
j=1 fi,j(Xg,j). We therefore use quantile regression to estimate the
fi,js. To assure the large µg,i assumption is satisfied, instead of fixing the quantile choice, we use
median regression on a subset of genes with average counts beyond a lower bound.









and that the distribution of θg,i does not depend on i, to use subset quantile normalization (Wu and
Aryee, 2010).
The specifics of our algorithm are as follows:
1. Select a subset of genes with Y¯g,. > 50. Then for each i, use median regression on log(Yg,i)
to estimate the parameters that define the splines fi,j and determine fˆi,j .
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2. For each i, apply quantile normalization to log(Yg,i)−
∑p
j=1 fˆi,j(Xg,j) to obtain hˆ
−1
i .
3. For each gene g on each sample i, define a normalization offset as exp[log(Yg,i)−hˆ−1{log(Yg,i)−
fˆi,j(Xg,j)}].
The algorithm returns an offset rather than normalized data for two reasons. First, for interpretabil-
ity we want to preserve the data as counts, i.e. integer numbers. Due to the large sampling error,
small counts should be treated with caution thus users of the algorithm benefit from access to
these original counts. Second, the most widely used methodology for identifying differentially
expressed genes from RNA-seq data model the counts in a way that sampling error from counting
process (such as Poisson) and variation in gene expression (θ) are taken into account (Robinson
and others, 2010; Anders and Huber, 2010). Providing an offset allows direct application of these
existing methods which take counts as input and can be easily adapted to adjust for offsets.
While the algorithm allows one to correct for a variety of systematic biases, we have consistently
used GC content and gene length. An R package cqn implementing the method is being submitted
to Bioconductor.
5 Results
Because experimentally controlling for the amount of RNA extracted from a sample is difficult, the
total number of counts varies across samples and manifests itself as between sample differences in
the locations of the log read-count distributions (Figure 1(a)). This unwanted technical variability
is further augmented by the differences in cDNA amplification efficiency (Aird and others, 2011)
and other technical artifacts and differences in distribution shapes and scales persist after library
size is taken into account. Scaling normalization based on more robust estimates of the shift in
location (Bullard and others, 2010; Robinson and Oshlack, 2010; Anders and Huber, 2010) can
provide further improvement, although improvement is limited in the samples we have analyzed (as
an example, results for trimmed median of M-values, TMM, from (Robinson and Oshlack, 2010)
are shown below). In contrast, our normalization approach (CQN) results in sample distributions
with comparable scales and shapes, as discussed below.
To demonstrate the down-stream advantages of our algorithm we first considered comparisons
between two samples. For illustrative purposes we selected two samples with very different sys-
tematic bias patterns (fi,js). For the assessment, we focused on fold-change as it is considered the
basic unit for differential expression analysis. We computed log-fold-change for each gene after
both RPKM normalization and CQN and a substantial improvement was observed (Figure 1(e,f)).
Specifically, while the RPKM showed a strong dependence between fold-change and GC-content,
CQN eliminated it.
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The resulting estimates of fˆi,j provided a useful quality assessment since plotting these demon-
strated a wide range of GC-content and gene length effects (Figure 3(c) and (d)). In the data sets
we analyzed, length effects were more consistent between samples than GC-effects. For many
samples the length effect is close to linear with a constant slope for genes shorter than 5000 bp.
This result implies that dividing by gene length, as done by the RPKM approach, is suitable in
most circumstances. However, we observed that for genes shorter than 1000bp the length effect
appears to be stronger, while for genes beyond 5000bp the length effect plateaus. This suggests
that dividing by gene length may not always be appropriate. A sample-specific gene length effect
may capture sample specific fragmentation bias as well as differences in size selection.
We have illustrated the potential downstream consequences of not normalizing with a comparison
of two samples (Figure 1). To demonstrate the advantages of CQN in a study with replicates, we
performed a five versus five comparison of biological replicates, between which we expect little
difference. Systematic bias was observed in the average log fold changes with a strong dependence
on GC content, using standard RPKM (Figure 3(e)). These problems were removed by CQN
(Figure 3(f)). The log-fold-variation was noticeably reduced by CQN (Figure 4(a)).
To perform a global assessment of precision, we compared the 29 Hapmap samples processed by
both the Cheung and the Montgomery studies. For each gene we computed the mean squared
difference between the expression measures from the two technical replicates. Our approach im-
proved precision greatly as shown in Figure 4(b): the median mean squared difference was reduced
by 42% after normalization. Note that this shows improvements in across study comparisons.
Finally, to assure that the gains in precision were not achieved by simply reducing overall dynamic
range, we assessed accuracy by comparing RNA-seq counts to measurements from an indepen-
dent technology: microarrays. Specifically, we computed log-fold-change values between UHR
and brain and averaged these across all replicates. We did this for both microarrays and sequenc-
ing counts and then compared the agreement with microarrays to sequencing counts after RPKM
normalization or CQN. We found similar accuracy (Figure 4(c)): between technology correlations
were 0.84 using CQN normalization compared to 0.85 using standard RPKM. Indeed, using stan-
dard RPKM instead of CQN normalization produced a plot very similar to Figure 4(c) (not shown).
6 Discussion
Unlike previous reports based on small samples, by examining large datasets processed from four
different studies, we found RNA-seq data to be greatly affected by bias and systematic errors. Just
as with microarrays, we found that lack of normalization can lead to false positives in a differential
expression analysis. Particularly, sample specific GC-content effects led to confounding of GC-
content and observed log-fold-change values. Apart from correcting for biases such as GC-content,
we also found a need to quantile normalize the data to correct for sample-specific distortion. To
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remove these unwanted sources of variation we developed a normalization procedure for RNA-seq
data that greatly improves precision without affecting accuracy. We demonstrated the improve-
ments with comparisons of two biological samples and a five versus five example. Although in a
comparison with many biological replicates the observed sample specific biases may cancel out,
large studies are not the norm due to the cost and current optimistic view of the technology’s pre-
cision (Hansen and others, 2011). More importantly, we show a great increase in precision across
studies using CQN.
The datasets used for evaluating our method consists of the largest number of biological replicates
in the literature. Unlike the situation for microarrays, there is no reference dataset with biological
replicates available, in which the expression changes are known for a subset of genes. Thus we
were limited to using different datasets for evaluating precision and accuracy.
Normalization methods developed earlier, including the RPKM measure and the various forms of
modified scaling normalization (Bullard and others, 2010; Robinson and Oshlack, 2010; Anders
and Huber, 2010), considered the sample effect as common for all genes, and thus only one scaling
factor is estimated in a sample. Although RPKM takes gene length into account, the effect of this
length covariate is considered static and constant for all samples. By studying four different RNA-
seq datasets we found that these assumptions do not always hold. In practice, the GC-content effect
may vary substantially between samples and the same is true to a lesser degree for gene length.
In general, our approach to quantifying systematic biases was useful for quality assessment as it
identified specific particularly problematic samples (Figures 3(c,d)).
Instead of returning a normalized version of the data, our procedure returns a gene specific nor-
malization offset. This allows direct adaptation of existing methodology with a generalized linear
model structure. For example, Robinson and others (2010) use an offset that is sample specific but
common to all genes in a sample, a value similar to library size but estimated from the data. This
offset essentially makes the mean M value in the MA plot equal to zero. We have demonstrated
that this approach does not remove GC-content effects. However, by incorporating our offset into
their method, this problem is easily solved. Anders and Huber (2010) model counts with a nega-
tive binomial distribution in which the mean of a gene is similarly proportional to a sample specific
offset that represents sequencing depth. This model can also be easily adapted by replacing this
size factor by the offset estimated by CQN.
Quantile normalization has been widely applied to microarray data and shown to have excellent
performance compared with competing nonlinear normalization methods (Bolstad and others,
2003). We found that when there are known and measurable confounders, as in the RNA-seq
example, estimating and removing their effects before quantile normalization provides further ad-
vantage. For the results presented here, we considered only two covariates, GC-content and gene
length, but our model permits the inclusion of others: for example, mappability or more elaborate
sequence effects. Although the biochemical and technical mechanisms for the inconsistent sys-
tematic biases between samples are not fully explained, these biases can be estimated and adjusted
9
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for because of the high throughput nature of RNA-seq technology. Even in situations in which
direct quantile normalization has been considered useful, we suggest using exploratory plots (Fig-
ures 3(c,d)) before applying quantile normalization.
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Figure 1. Exploratory plots. (a) The points show the frequency of counts in the bins shown on
the x-axis. The three colors represent three samples (NA12812, NA12874, NA11993) from the
Montgomery data. (b) log2 RPKM values are stratified by GC-content for two biological
replicates from the Montgomery data (NA11918, NA12761) and are summarized by boxplots.
The two samples are distinguished by the two colors. Genes with average (across all 60 samples)
log2 RPKM values below 2 are not shown. (c) Log-fold changes between RPKM values from the
two samples and the same genes shown in (b) were computed and are plotted against GC-content.
Red is used to show the genes with the 10% highest GC-content and blue is used to show the
genes with the 10% lowest GC-content. (d) RPKM log-fold-changes are plotted against average
log2 counts for the samples and genes shown in (b), with the same color coding as in (c). (e) As
(d) but from values corrected using the method proposed by Pickrell and others (2010). (f) As (d)
but for values normalized using our approach (see Methods).
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Figure 2. Empirical distributions. (a) Empirical density estimates of log(Yg,i)− fˆi,j(Xg,j) are
shown for six samples from the Montgomery data. (b) A histogram of counts in a single sample
for genes with a GC content of 45% ± 1% and with a length between 500bp and 2,000bp is
shown.
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Figure 3. Results from normalizing 60 samples. In these plots we only show genes with a length
greater than 100bp and an average (across all 60 samples) standard log2-RPKM of 2 or greater.
(a) Empirical density estimates of log2-RPKM for five different biological replicates from the
Montgomery data are shown. (b) As (a) but CQN normalized expression values on the log2-scale
are shown. (c) The estimated GC-content effect are shown as curves for all 60 biological
replicates in the Montgomery study. We created a five versus five comparison using the samples
highlighted in blue (group 1) and red (group 2). (d) as (c) but curves are shown for the gene
length effect instead of GC-content. (e) Average log-fold-change is plotted against GC-content.
Here we used RPKM values and compared group 2 to group 1. (f) Average log-fold-change is
plotted against GC-content using CQN normalized expression measures.
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Figure 4. Improved precision provided by CQN on comparisons across studies. (a) We show
boxplots of the estimated log fold change between the two groups of five samples (the same two
groups as in Figure 3) from the Montgomery data using standard RPKM, expression values
normalized by TMM (trimmed median of M-values, the method proposed in Robinson and
Oshlack (2010)), the method proposed in Pickrell and others (2010), and CQN. We show genes
with length greater than 100bp and average (across all samples) log2 RPKM greater or equal to
two. (b) We normalized the 29 samples assayed in both Montgomery and Cheung. For each gene
we computed the mean squared difference between the expression measure based on the
Montgomery and the Cheung data. The boxplots show the distribution of these precision
measures for the highly expressed genes, for each of the four choices of normalization: standard
RPKM , TMM, the method proposed in Pickrell and others (2010) and CQN. We show genes
with length greater than 100bp and average (across all samples) log2 RPKM greater or equal to
two. (c) For the MAQC data we obtained fold change estimates between UHR and brain based on
RNA-Seq and microarrays. For RNA-seq we used two samples. For the microarrays we used a
five versus five comparison. The microarray data was normalized using RMA and the RNA-seq
data was normalized by CQN.
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